Infusible Platelet Membranes Retain Partial Functionality of the Platelet GPIb/IX/V Receptor Complex

American Journal of Clinical Pathology

Volumn 115, Issue 1, 2001, Pages 144-147

  Graham, Susan S ^a   Gonchoroff, Nick J ^a   Miller, Jonathan L ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Glycoprotein Ib IX V; Hemostasis; Infusible platelet membranes; Platelet transfusion; Von Willebrand Factor

Indexed keywords

BOTROCETIN; MONOCLONAL ANTIBODY; RISTOCETIN; SNAKE VENOM; THROMBIN RECEPTOR; VON WILLEBRAND FACTOR;

ARTICLE; CELL MEMBRANE; COMPARATIVE STUDY; DRUG ANTAGONISM; HUMAN; IMMUNOLOGY; METABOLISM; THROMBOCYTE; THROMBOCYTE TRANSFUSION;

ANTIBODIES, MONOCLONAL; BLOOD PLATELETS; CELL MEMBRANE; CROTALID VENOMS; HUMANS; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PLATELET TRANSFUSION; RISTOCETIN; VON WILLEBRAND FACTOR;

EID: 0035227457     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/CCDV-3BEP-XXKP-BKDM     Document Type: Article

References (15)

1. Chao FC, Kim BK, Houranieh AM, et al. Infusible platelet membrane (IPM) is a potential substitute for platelets in transfusion: correction of prolonged bleeding time in thrombocytopenic rabbits [abstract]. Thromb Haemost. 1993;69:750.
2. Chao FC, Kim BK, Houranieh AM, et al. Infusible platelet membrane microvesicles: a potential transfusion substitute for platelets. Transfusion. 1996;36:536-542.
3. Galan AM, Bozzo J, Hernandez MR, et al. Infusible platelet membranes improve hemostasis in thrombocytopenic blood: experimental studies under flow conditions. Transfusion. 2000;40:1074-1080.
4. Kroll MH, Hellums JD, McIntyre LV, et al. Platelets and shear stress. Blood. 1996;88:1525-1541.
5. Miller JL, Kupinski JM, Castella A, et al. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease. J Clin Invest. 1983;72:1532-1542.
6. Miller JL, Hustad KO, Kupinski JM, et al. Increased platelet sensitivity to ristocerin is predicted by the binding characteristics of a GPIb/IX determinant. Br J Haematol. 1990;74:313-319.
7. Lacbawan FL, Thompson MR, Miller JL. Formalin fixation of platelets differentially affects the ability of anti-GPIB monoclonal antibodies to inhibit von Willebrand factor-dependent agglutination [abstract]. Thromb Haemost. 1995;73:1126.
8. Shen Y, Romo GM, Dong JF, et al. Requirement of leucine-rich repeats of glycoprotein (GP) Ibalpha for shear-dependent and static binding of von Willebrand factor to the platelet membrane GP Ib-IX-V complex. Blood. 2000;95:903-910.
9. Andrews RK, Booth WJ, Gorman JJ, et al. Purification of botrocetin from Bothrops jararaca venom: analysis of the notrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex. Biochemistry. 1989;28:8317-8326.
10. Berndt MC, Du XP, Booth WJ. Ristocetin-dependent reconstitution of binding of von Willebrand factor to purified human platelet membrane glycoprotein Ib-IX complex. Biochemistry. 1988;27:633-640.
11. Scott JP, Montgomery RR, Retzinger GS. Dimeric ristocetin flocculates proteins, binds to platelets, and mediates von Willebrand factor-dependent agglutination of platelets. J Biol Chem. 1991;266:8149-8155.
12. Kao K, Pizzo SV, McKee PA. Demonstration and characterization of specific binding sites for factor VIII/von Willebrand factor on human platelets. J Clin Invest. 1979;63:656-664.
13. Rivera J, Sánchez-Roig MJ, Rosillo MC, et al. Stability of glycoproteins Ib/IX and IIb/IIIa during preparation and storage of platelet concentrates: detection by binding assays with epitope-defined monoclonal antibodies and physiological ligands. Vox Sang. 1994;67:166-171.
14. Ribeiro A, Swann JC, Berndt MC. Alterations of the levels of glycoproteins Ib-IX and IIb-IIIa in platelets stored at 22°C. Thromb Res. 1992;66:619-627.
15. Alving BM, Reid TJ, Fratantoni JC, et al. Frozen platelets and platelet substitutes in transfusion medicine. Transfusion. 1997;37:866-876.